ZBNA
NBIX icon

Zions Bancorporation, National Association’s Neurocrine Biosciences NBIX Stock Holding History

Zions Bancorporation, National Association’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
73
+34
+87% +$5.04K ﹤0.01% 870
2026
Q1 		$5.14K Buy
39
+31
+388% +$4.11K ﹤0.01% 994
2025
Q4 		$1.14K Buy
+8
New +$1.16K ﹤0.01% 1077

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Zions Bancorporation, National Association's NBIX Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Neurocrine Biosciences (NBIX) stake by 87% in Q2 2026, buying an estimated $5.04K and bringing the position to 73 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

Zions Bancorporation, National Association first reported a position in NBIX in Q4 2025 and has held it in 3 quarters since. 779 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Zions Bancorporation, National Association held 73 shares of Neurocrine Biosciences worth $12.3K as of Q2 2026.
  • Zions Bancorporation, National Association bought 34 Neurocrine Biosciences shares in Q2 2026, an estimated $5.04K.
  • Neurocrine Biosciences made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #870 holding.
  • Zions Bancorporation, National Association first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 779 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.